SELLAS Life Sciences (SLS) Return on Equity (2011 - 2026)
SELLAS Life Sciences (SLS) reported Return on Equity of 0.0% for Q1 2026, up 1.0% year-over-year from 0.0% in Q1 2025, and up 28.34% on a QoQ basis from 0.0% in Q4 2025.
SELLAS Life Sciences (SLS) has 15 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Equity rose 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 41.0% from the prior year.
- Return on Equity rose to 0.0% in Q1 2026 per SLS's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Equity topped out at 0.06% in Q4 2023 and bottomed at 0.76% in Q3 2023.
- The 5-year median for Return on Equity is 0.03% (2022), against an average of 0.09%.
- The widest annual swing landed in 2023, when Return on Equity sank 74 bps; it then jumped 73 bps in 2024.
- Tracing SLS's Return on Equity over 5 years: stood at 0.05% in 2022, then jumped by 232 bps to 0.06% in 2023, then slumped by 138 bps to 0.02% in 2024, then jumped by 81 bps to 0.0% in 2025, then rose by 28 bps to 0.0% in 2026.
- Per Business Quant, the three latest SLS Return on Equity figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -0.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.01% |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.42% |
| Dec 31, 2023 | 0.06% |
| Sep 30, 2023 | -0.76% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | -0.01% |
| Mar 31, 2020 | -0.01% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | 0.04% |
| Mar 31, 2018 | -0.26% |
| Dec 31, 2017 | -0.02% |
| Sep 30, 2017 | -0.01% |
| Jun 30, 2017 | -0.01% |
| Mar 31, 2017 | -0.02% |
| Dec 31, 2016 | -0.01% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.02% |
| Mar 31, 2016 | -3.46% |
| Dec 31, 2015 | -0.02% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 0.00% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2014 | 0.00% |
| Sep 30, 2014 | -0.01% |
| Jun 30, 2014 | -0.01% |
| Mar 31, 2014 | -0.01% |
| Dec 31, 2013 | -0.01% |
| Sep 30, 2013 | -0.01% |
| Jun 30, 2013 | -0.01% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | 0.00% |
| Mar 31, 2012 | 0.31% |
| Dec 31, 2011 | -0.01% |
| Sep 30, 2011 | -0.01% |